Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis (Q27002495)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis	scientific article

Statements

scholarly article

1 reference

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis (English)

0 references

carbapenem antibiotic

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

Enterobacteriaceae

1 reference

based on heuristic

inferred from title

author name string

K. Z. Vardakas

1

1 reference

G. S. Tansarli

2

1 reference

P. I. Rafailidis

3

1 reference

M. E. Falagas

4

1 reference

language of work or name

1 reference

publication date

December 2012

1 reference

Journal of Antimicrobial Chemotherapy

1 reference

67

1 reference

2793-803

1 reference

12

1 reference

Extended-spectrum beta-lactamase-producing organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamases and clinical outcomes: current data

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Mortality rate in neonates infected with extended-spectrum beta lactamase-producing Klebsiella species and selective empirical use of meropenem.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

[Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Bioactive microbial metabolites

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS301

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27002495&oldid=1621843750"